실시간 바이오 인텔리전스 · ADC · CGT

함께 비교하는 진짜 ADC · Antibody · CGT 데이터

8,428+프로그램
40+FDA 승인
3,743+모집 중
ADC 1032·Antibody 4683·CGT 2713차세대 추천 →·Data Tier →
8428프로그램40FDA 승인
174오늘 방문
5,300누적 방문
7303갱신 대기S–CData TierS/A/B차세대→Insight1032HER2 breast4683Antibody2713CGT→Psoriasis→NSCLC40FDA 승인
피드Data Tier차세대Insight

추천 비교

비교 도구 →
HER2 ADCEnhertu · Kadcyla · RC48CD19 CAR-TYescarta · KymriahPD-1Keytruda · Opdivo다발골수종Darzalex · BlenrepTROP2 ADCTrodelvy · Dato-DXd · SGNectin-4 · TROP2Padcev · Trodelvy건선 IL pathwayStelara · Cosentyx · SkyriziAnti-VEGF (안과)Eylea · LucentisAnti-TNFHumira · EnbrelIL-12/23Stelara · Skyrizi아토피·IL-13Dupixent · EbglyssPCSK9 · LDLRepatha · Praluent · LeqvioGLP-1 · incretinSemaglutide · Tirzepatide혈우병 유전자치료Hemgenix · Roctavian겸상적혈구 CGTCasgevy · Lyfgenia망막·DMD 유전자치료Luxturna · Elevidys

빠른 검색 · 이슈 태그

인기최근 업데이트큐레이션임상 많은갱신 필요ORR최신Phase 3FDA승인프로그램 3,526개
다음 갱신 D-8 · 마지막 7월 21일
CGTBiologicstaleYake Biotechnology Ltd.Phase 1

chimeric antigen receptor T cell treatment (chimeric antigen receptor T cell treatment)

T Cell Lymphoma; T-cell Leukemia · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
CGTBiologicstaleGenzyme, a Sanofi CompanyPhase 2

stem cells (stem cells)

Acute Lymphoblastic Leukemia; Acute Myelocytic Leukemia · Acute Lymphoblastic Leukemia

#AcuteLymphoblasticLeukemia#CGT#Phase2#인기#세포유전치료+5
임상시험 62상태 DISCONTINUED
ADCBiologicstaleSuzhou Suncadia Biopharmaceutic…rezetecanPhase 3

SHR-A1811 (SHR-A1811)

Breast Cancer; HER2-positive Breast Cancer · HER2

#HER2#ADC#Phase3#인기#항체약물접합체+5
임상시험 62상태 RECRUITING
CGTBiologicstalePorteus, Matthew, MDPhase 1

Allogeneic Stem Cell Transplant (Allogeneic Stem Cell Transplant)

Hematologic Diseases · Hematologic Diseases

#HematologicDiseases#CGT#Phase1#인기#세포유전치료+4
효능 ORR 72.7%임상시험 62상태 RECRUITING
AntibodystaleAkesogovitecan), and chimeric an…Phase 2

Ivonescimab (Ivonescimab)

Advanced Microsatellite Stable Colorectal Carcinoma; Metastatic Microsatellite Stable Colorectal Carcinoma · HER2

#HER2#Antibody#Phase2#인기#항체+5
임상시험 62상태 RECRUITING
CGTBiologicstaleShanghai Unicar-Therapy Bio-med…Phase 1

chimeric antigen receptor T cell (chimeric antigen receptor T cell)

Pancreatic Cancer; CAR · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
효능 ORR 67%임상시험 62상태 ACTIVE
ADCBiologicstaleCelyad Oncology SAPhase 2

Endoxan (Endoxan)

Relapse/Refractory Multiple Myeloma · Lymphoma, T-Cell, Peripheral

#LymphomaT-CellPeripheral#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 95%임상시험 62상태 ACTIVE
CGTBiologicstaleShenzhen BinDeBio Ltd.mayPhase 2

CAR-T cell immunotherapy (CAR-T cell immunotherapy)

B-cell Acute Lymphoblastic Leukemia; Lymphoma · GD2

#GD2#CGT#Phase2#인기#세포유전치료+5
효능 ORR 80.3%임상시험 62상태 ACTIVE
ADCBiologicstaleK36 Therapeutics, Inc.Phase 2

Dexamethasone oral (Dexamethasone oral)

Multiple Myeloma · Breast Neoplasms

#BreastNeoplasms#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 90%임상시험 62상태 RECRUITING
ADCBiologicstaleAmer Zureikatvedotin after avelumabPhase 2

Gemcitabine (Gemzar, Gemzar (Gemcitabine))

Pancreatic Cancer · Ovarian Neoplasms

#OvarianNeoplasms#ADC#Phase2#인기#항체약물접합체+5
임상시험 62상태 DISCONTINUED
CGTBiologicstaleMerck Sharp & Dohme LLCPhase 2

Stem cell infusion (Stem cell infusion)

Leukemia; Lymphoma · Leukemia

#Leukemia#CGT#Phase2#인기#세포유전치료+5
효능 ORR 90%임상시험 62상태 ACTIVE
CGTBiologicstaleFondazione Policlinico Universi…sPreclinical

Chimeric Antigen Receptor (Chimeric Antigen Receptor)

Lymphoma · Lymphoma

#Lymphoma#CGT#Preclinical#인기#세포유전치료+4
효능 ORR 67%임상시험 62상태 RECRUITING
ADCBiologicstaleARCAGYGovitecanPhase 2

GCSF (GCSF)

Ovarian Cancer · Diffuse Large B-cell Lymphoma

#DiffuseLargeB-cellLymphoma#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 20.4%임상시험 62상태 DISCONTINUED
CGTBiologicstaleAbbottPhase 1

valproic acid (valproic acid)

Advanced Malignant Neoplasm; Castleman Disease · FRα

#FR#CGT#Phase1#인기#세포유전치료+5
임상시험 62상태 DISCONTINUED
CGTBiologicstaleTakedaPhase 1

19 (T2, 19, 19(T2)28z1xx CAR T cells)

Diffuse Large B Cell Lymphoma; Primary Mediastinal Large B Cell Lymphoma · Diffuse Large B Cell Lymphoma

#DiffuseLargeBCellLymphoma#CGT#Phase1#인기#세포유전치료+5
효능 ORR 17%임상시험 62상태 RECRUITING
ADCBiologicstaleBristol-Myers SquibbPhase 1

Revlimid (Revlimid)

Lymphoma; Non-Hodgkin Lymphoma · Lymphoma

#Lymphoma#ADC#Phase1#인기#항체약물접합체+4
효능 ORR 90%임상시험 62상태 RECRUITING
ADCBiologicstaleThe Lymphoma Academic Research …vedotin plus doxorubicin [A…Phase 2

Oncovin (Oncovin)

Hodgkin Lymphoma · Hodgkin Lymphoma

#HodgkinLymphoma#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 95%임상시험 62상태 ACTIVE
AntibodystaleJanssenderuxtecan in ovarian cance…Phase 3

infliximab (Remicade, Remicade (infliximab))

Uveitis · Rheumatoid Arthritis

#RheumatoidArthritis#Antibody#Phase3#인기#항체+5
임상시험 62상태 ACTIVE
ADCBiologicstaleQuantumLeap Healthcare Collabor…Phase 2

Standard Therapy (Standard Therapy)

Breast Neoplasms; Breast Cancer · HER2

#HER2#ADC#Phase2#인기#항체약물접합체+5
효능 ORR 9%임상시험 62상태 RECRUITING
ADCBiologicstaleCelgenevedotin (BV) maintenance th…Phase 3

High Dose Chemotherapy (High Dose Chemotherapy)

Recurrent Classic Hodgkin Lymphoma; Refractory Classic Hodgkin Lymphoma · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5
효능 ORR 29%임상시험 62상태 RECRUITING
ADCBiologicstaleMedical Enterprises Europe B.V.Phase 3

Mitomycin C (Mitomycin C)

Locally Advanced Cancer in the Anal Region · Urothelial Cancer

#UrothelialCancer#ADC#Phase3#인기#항체약물접합체+4
임상시험 62상태 RECRUITING
ADCBiologicstaleMerck Sharp & Dohme LLCGovitecan in gynecologic ma…Phase 2

sac-TMT (Sacituzumab Tirumotecan, Sacituzumab Tirumotecan (sac-TMT))

Gastroesophageal Junction; Gastroesophageal Adenocarcinoma · Gastroesophageal Junction

#GastroesophagealJunction#ADC#Phase2#인기#항체약물접합체+5
임상시험 62상태 RECRUITING
CGTBiologicstaleZhongmou Therapeuticsvedotin in relapsed or refr…Phase 2

high dose (ZM-02, ZM-02 (high dose))

Retinitis Pigmentosa (RP) · Retinitis Pigmentosa (RP)

#RetinitisPigmentosaRP#CGT#Phase2#인기#세포유전치료+5
임상시험 62상태 RECRUITING
AntibodystaleBristol Myers SquibbPhase 2

Relatlimab (Relatlimab)

Various Advanced Cancer · FRα

#FR#Antibody#Phase2#인기#항체+5
효능 ORR 71.4%임상시험 62상태 RECRUITING
ADCBiologicstalePfizerPhase 2

Sunitinib Malate (Sunitinib Malate)

Advanced Lymphoma; Advanced Malignant Solid Neoplasm · FRα

#FR#ADC#Phase2#인기#항체약물접합체+4
효능 ORR 59%임상시험 61상태 RECRUITING

9 / 142 페이지

← 이전다음 →
전체 8,428개 프로그램 보기